✦ LIBER ✦

PCN80 Modelling the Cost-Effectiveness of Ipilimumab for Previously-Treated, Metastatic Melanoma

✍ Scribed by D. Lee; B. Winn; M. Lebmeier; A. Batty

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN87 Cost Effectiveness Evaluation of V

✍ M. Alva; J.G. Gay; R. Sanchez Kobashi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PCN58 BEVACIZUMAB FOR THE TREATMENT OF M

✍ A Fortune-Greeley; P Cornell 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

A cost effectiveness study of eribulin v

✍ Gilberto Lopes, Stefan Glück, Kiran Avancha, Alberto J. Montero 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 346 KB

PCN83 Cost Effectiveness Analysis in the

✍ P.R. Maran; A. Aiello; M.R. Magrì; C. Alberti; E. Visentin; F. Venturini; G. Scr 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PCN6: MODELLING THE LONG-TERM COST EFFEC

✍ M Tavakoli; HTO Davies; M Malek 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PCN25 CONSIDERATIONS FOR MODELING THE CO

✍ CF Bell; CL McDade; L Black; SR Earnshaw; MW Kattan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB